| All subjects | P | Matched case - control subjects | P | ||
---|---|---|---|---|---|---|
Women without GDM | Women with GDM | Women without GDM | Women with GDM | |||
Anthropometric parameters | ||||||
 N | 493 | 96 | / | 91 | 91 | / |
 Age (years) | 30.29 ± 4.41 | 31.24 ± 4.60 | 0.040 | 30.91 ± 4.42 | 31.04 ± 4.41 | 0.798 |
 Parity (n, %) |  |  | 0.368 |  |  | 0.628 |
  Nulliparous | 142 (35.4) | 29 (30.5) |  | 26 (28.6) | 29 (31.9) |  |
  Parous | 259 (64.6) | 66 (69.5) |  | 65 (71.4) | 62 (68.1) |  |
 Pre-pregnancy BMI (kg/m2) | 21.69 ± 3.08 | 23.44 ± 3.99 | < 0.001 | 22.87 ± 2.96 | 22.94 ± 3.00 | 0.658 |
First trimester | ||||||
 Gestation weeks | 10.93 ± 3.11 | 11.29 ± 3.68 | 0.63 | 11.63 ± 4.21 | 11.23 ± 3.68 | 0.211 |
 SBP (mmHg) | 116.37 ± 10.86 | 117.61 ± 10.05 | 0.220 | 118.19 ± 9.73 | 117.25 ± 10.04 | 0.401 |
 DBP (mmHg) | 71.02 ± 8.53 | 71.44 ± 9.17 | 0.011 | 72.09 ± 8.59 | 71.16 ± 9.26 | 0.467 |
 Weight (kg) | 57.44 ± 8.58 | 60.68 ± 9.60 | < 0.001 | 60.51 ± 8.05 | 59.94 ± 8.74 | 0.785 |
 Height (cm) | 1.60 ± 0.05 | 1.59 ± 0.06 | 0.030 | 1.60 ± 0.04 | 1.59 ± 0.05 | 0.318 |
 WBC (× 109/L) | 8.62 ± 2.05 | 8.98 ± 1.78 | 0.030 | 8.61 ± 2.22 | 8.95 ± 1.82 | 0.044 |
 Neutrophils (× 109/L) | 6.27 ± 1.40 | 6.81 ± 1.46 | 0.005 | 6.21 ± 1.42 | 6.80 ± 1.49 | 0.008 |
 ALT (U/L) | 10.00 (8.00–15.00) | 10.00 (8.00–14.75) | 0.950 | 11.00 (8.00–15.75) | 10.00 (8.00–14.00) | 0.452 |
 BUN (mmol/L) | 2.60 (2.10–3.10) | 2.44 ± 0.59 | 0.010 | 2.61 ± 0.74 | 2.43 ± 0.61 | 0.182 |
 SCR (umol/L) | 51.57 ± 9.29 | 50.02 ± 7.79 | 0.190 | 51.61 ± 8.72 | 50.19 ± 7.87 | 0.267 |
 TC (mmol/L) | 4.39 (3.95–4.98) | 4.49 (4.01–4.90) | 0.750 | 4.56 ± 0.75 | 4.46 ± 0.69 | 0.385 |
 TG (mmol/L) | 1.34 (1.07–1.75) | 1.62 (1.25–2.00) | < 0.001 | 1.55 (1.19–2.06) | 1.59 (1.24–2.02) | 0.792 |
 HDL (mmol/L) | 1.82 (1.59–2.04) | 1.79 (1.51–1.99) | 0.040 | 1.78 ± 0.35 | 1.74 ± 0.36 | 0.683 |
 LDL (mmol/L) | 2.48 ± 0.69 | 2.47 ± 0.59 | 0.610 | 2.56 ± 0.65 | 2.46 ± 0.59 | 0.455 |
 FPG (mmol/L) | 4.40 (4.14–4.62) | 4.47 (4.22–4.81) | 0.020 | 4.35 (4.16–4.56) | 4.47 (4.22–4.79) | 0.021 |
 eGFR (CDK-EPI) (mL/min/1.73m2) | 124.24 ± 10.63 | 124.39 ± 8.27 | 0.780 | 123.77 ± 9.97 | 124.42 ± 8.41 | 0.595 |
 eGFR (MDRD) (mL/min/1.73m2) | 134.50 ± 29.90 | 136.82 ± 24.77 | 0.390 | 133.81 ± 27.90 | 136.54 ± 25.02 | 0.306 |
 NE (ng/mL)a | 2.58 ± 0.26 | 2.70 ± 0.24 | < 0.001 | 2.57 ± 0.24 | 2.69 ± 0.23 | < 0.001 |
 PR3 (ng/mL)a | 1.94 ± 0.23 | 2.00 ± 0.21 | 0.014 | 1.93 ± 0.21 | 2.00 ± 0.21 | 0.040 |
Second trimester | ||||||
 Gestation weeks | 25.90 ± 1.40 | 25.81 ± 1.74 | 0.75 | 25.79 ± 1.52 | 25.80 ± 1.77 | 0.467 |
 NE (ng/mL) | 476.06 (349.26–839.20) | 602.29 (429.80–760.82) | 0.391 | 437.19 (349.05–974.50) | 542.65 (359.41–704.15) | 0.706 |
 PR3 (ng/mL) | 91.50 (67.83–117.19) | 95.23 (68.06–138.40) | 0.280 | 99.14 (69.94–174.84) | 92.18 (63.47–135.90) | 0.606 |
 FPG (mmol/L) | 4.35 ± 0.37 | 4.84 ± 0.58 | < 0.001 | 4.39 (4.15–4.51) | 4.66 (4.38–5.26) | < 0.001 |
 1 h PG (mmol/L) | 7.01 ± 1.59 | 9.86 ± 1.59 | < 0.001 | 7.18 ± 1.47 | 9.90 ± 1.60 | < 0.001 |
 2 h PG (mmol/L) | 6.01 ± 1.12 | 8.19 ± 1.59 | < 0.001 | 6.07 ± 1.00 | 8.18 ± 1.61 | < 0.001 |
 OGTT area | 12.18 ± 2.04 | 16.38 ± 2.18 | < 0.001 | 12.40 ± 1.80 | 16.41 ± 2.20 | < 0.001 |
 WBC (× 109/L) | 9.52 ± 2.27 | 9.66 ± 1.95 | 0.250 | 9.49 ± 2.21 | 9.60 ± 1.93 | 0.441 |
 Neutrophils (× 109/L) | 7.03 ± 1.98 | 7.12 ± 1.62 | 0.270 | 6.98 ± 1.96 | 7.08 ± 1.61 | 0.365 |
Third trimester | ||||||
 Delivery time (weeks) | 39.0 ± 1.46 | 38.5 ± 1.54 | 0.003 | 38.8 ± 1.58 | 38.5 ± 1.56 | 0.078 |
 HBA1C (%) | 5.41 ± 0.43 | 5.62 ± 0.46 | 0.180 | 5.63 ± 0.26 | 5.62 ± 0.48 | 0.830 |
 FPG (mmol/L) | 4.02 ± 0.65 | 4.43 ± 0.69 | < 0.001 | 3.83 ± 0.43 | 4.40 ± 0.70 | 0.002 |
 Weight gain (kg) | 12.73 ± 4.52 | 9.99 ± 4.98 | < 0.001 | 11.98 ± 4.52 | 10.00 (7.00–13.50) | 0.013 |
Pregnancy outcomes | ||||||
 Newborn weight (kg) | 3.27 ± 0.45 | 3.32 ± 0.53 | 0.090 | 3.24 ± 3.91 | 3.33 ± 4.77 | 0.042 |
 Macrosomia (n, %) |  |  | 0.403 |  |  | 0.660 |
  No | 302 (95.6) | 69 (93.2) |  | 68 (97.1) | 68 (95.8) |  |
  Yes | 14 (4.4) | 5 (6.8) |  | 2 (2.9) | 3 (4.2) |  |
 Fetus gender (n, %) |  |  | 0.282 |  |  | 0.935 |
  Male | 143 (45.3) | 39 (52.7) |  | 36 (51.4) | 37 (52.1) |  |
  Female | 173 (54.7) | 35 (47.3) |  | 34 (48.6) | 34 (47.9) |  |
 Comprehensive adverse fetal outcomes (n, %) |  |  | 0.001 |  |  | 0.058 |
  No | 284 (89.9) | 57 (77.0) |  | 64 (91.4) | 57 (80.3) |  |
  Yes | 32 (10.1) | 17 (23.0) |  | 6 (8.6) | 14 (19.7) |  |
 Cesarean section (n, %) |  |  | 0.082 |  |  | 0.592 |
  No | 212 (67.1) | 42 (56.8) |  | 42 (60) | 40 (56.3) |  |
  Yes | 104 (32.9) | 32 (43.2) |  | 28 (40) | 31 (43.7) |  |
 Preeclampsia (n, %) |  |  | 0.532 |  |  | 0.316 |
  No | 491 (99.6) | 95 (99.0) |  | 91 (100) | 90 (98.9) |  |
  Yes | 2 (0.4) | 1 (1.0) |  | 0 (0) | 1 (1.1) |  |
 Gestational hypertension (n, %) |  |  | 0.498 |  |  | 0.470 |
  No | 386 (96.3) | 91 (94.8) |  | 88 (96.7) | 86 (94.5) |  |
  Yes | 15 (3.7) | 5 (5.2) |  | 3 (3.3) | 5 (5.5) |  |